SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Variable Lease, Cost
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Variable Lease, Cost of $16.34 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for the quarter ending 2026-06-30 was $16.34K, a 80.49% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for the quarter ending 2026-03-31 was $16.34K, a 50.19% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for the quarter ending 2025-12-31 was $37.42K, a 258.46% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for the quarter ending 2025-09-30 was $10.88K, a 4.20% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for fiscal 2025 was $68.23K, a 65.38% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for fiscal 2024 was $41.26K, a 70.33% increase from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. variable lease, cost for fiscal 2023 was $24.22K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.34K 10-Q · filed 2026-09-24 | $32.68K 10-Q · filed 2026-09-24 | $70.10K derived: sum of 3 quarters · filed 2026-09-24 | $80.98K derived: sum of 4 quarters · filed 2026-09-24 |
| 2026-03-31 | $16.34K 10-Q · filed 2026-05-15 | $53.76K derived: sum of 2 quarters · filed 2026-05-15 | $64.64K derived: sum of 3 quarters · filed 2026-05-15 | $73.69K derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-12-31 | $37.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $48.30K derived: sum of 2 quarters · filed 2026-03-31 | $57.35K derived: sum of 3 quarters · filed 2026-09-24 | $68.23K 10-K · filed 2026-03-31 |
| 2025-09-30 | $10.88K 10-Q · filed 2025-11-13 | $19.93K derived: sum of 2 quarters · filed 2026-09-24 | $30.81K 10-Q · filed 2025-11-13 | $41.25K derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-06-30 | $9.05K 10-Q · filed 2026-09-24 | $19.93K 10-Q · filed 2026-09-24 | $30.37K derived: sum of 3 quarters · filed 2026-09-24 | $40.81K derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-03-31 | $10.88K 10-Q · filed 2026-05-15 | $21.32K derived: sum of 2 quarters · filed 2026-05-15 | $31.76K derived: sum of 3 quarters · filed 2026-05-15 | $41.70K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $10.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $20.88K derived: sum of 2 quarters · filed 2026-03-31 | $30.82K derived: sum of 3 quarters · filed 2026-03-31 | $41.26K 10-K · filed 2026-03-31 |
| 2024-09-30 | $10.44K 10-Q · filed 2025-11-13 | $20.38K derived: sum of 2 quarters · filed 2025-11-13 | $30.82K 10-Q · filed 2025-11-13 | $41.32K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $9.94K 10-Q · filed 2025-08-13 | $20.38K 10-Q · filed 2025-08-13 | $30.88K derived: sum of 3 quarters · filed 2025-08-13 | $41.28K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $10.44K 10-Q · filed 2025-05-08 | $20.94K derived: sum of 2 quarters · filed 2025-05-08 | $31.35K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $10.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $20.91K derived: sum of 2 quarters · filed 2025-02-26 | $24.22K 10-K · filed 2025-02-26 | |
| 2023-09-30 | $10.41K 10-Q · filed 2024-11-13 | $13.72K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |